瑞阳制药有限公司招聘

Reyoung Pharmaceutical Co., Ltd., established in 1966, is now a Singapore-listed company with a total asset value of USD 500 million and over 4000 employees. The company's headquarters is located in Yiyuan, Shandong, with branches in Songjiang District, Shanghai, and research and development centers in Yiyuan, Jinan, Shanghai, and the United States. More than 160 offices are spread across major cities in China, and its products are exported to over thirty countries including Germany, France, and South Korea.

The company's main business areas include the research and production of pharmaceuticals, covering categories such as powdered injections, raw materials, solid formulations, and traditional Chinese medicine formulations. It specializes in the development of anti-cancer drugs, new antibiotic drugs, vaccines, and treatment drugs. Reyoung is one of the largest cephalosporin raw material drug production bases in China, ranking among the top five in the country for powdered injection production. Additionally, it collaborates with over 30 universities and research institutions, including Tsinghua University and Shandong University, holding numerous patents and winning national science and technology awards. The company has undertaken five national projects and drafted standards for 42 new drug products.

Over the past four decades, Reyoung has adhered to the principle of "benefiting all quarters through Reyoung Pharmaceuticals," focusing on the development of new products and technologies, maintaining steady growth through strict quality assurance systems. The company actively participates in social welfare activities and ranks among the top 20 leading pharmaceutical companies in China. In the future, Reyoung will continue to provide high-quality products to benefit society and create high-quality employment opportunities, welcoming talented individuals to join their team.

With a footprint spanning over 343,000 square meters, Reyoung Pharm. has more than 4000 employees, approximately 21% of whom are engaged in sales and marketing. All workshops have obtained GMP certification from the Chinese SFDA, capable of producing eight categories and over 340 specifications of pharmaceutical products including tablets, capsules, granules, sterile active ingredients, small volume injections, powdered injections, freeze-dried powders for injection, and suppositories. Its sales and marketing network covers all major cities in mainland China.